Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice

Regul Toxicol Pharmacol. 2016 Apr:76:234-61. doi: 10.1016/j.yrtph.2015.11.020. Epub 2015 Dec 10.

Abstract

Case studies covering carbonaceous nanomaterials, metal oxide and metal sulphate nanomaterials, amorphous silica and organic pigments were performed to assess the Decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping). The usefulness of the DF4nanoGrouping for nanomaterial hazard assessment was confirmed. In two tiers that rely exclusively on non-animal test methods followed by a third tier, if necessary, in which data from rat short-term inhalation studies are evaluated, nanomaterials are assigned to one of four main groups (MGs). The DF4nanoGrouping proved efficient in sorting out nanomaterials that could undergo hazard assessment without further testing. These are soluble nanomaterials (MG1) whose further hazard assessment should rely on read-across to the dissolved materials, high aspect-ratio nanomaterials (MG2) which could be assessed according to their potential fibre toxicity and passive nanomaterials (MG3) that only elicit effects under pulmonary overload conditions. Thereby, the DF4nanoGrouping allows identifying active nanomaterials (MG4) that merit in-depth investigations, and it provides a solid rationale for their sub-grouping to specify the further information needs. Finally, the evaluated case study materials may be used as source nanomaterials in future read-across applications. Overall, the DF4nanoGrouping is a hazard assessment strategy that strictly uses animals as a last resort.

Keywords: Amorphous silica nanomaterials; Apical toxic effects; Biopersistence and biodistribution; Carbonaceous nanomaterials; Cellular effects; Grouping; Intrinsic material and system-dependent properties; Metal oxide and metal sulphate nanomaterials; Organic pigments; Read-across.

MeSH terms

  • Animals
  • Benchmarking
  • Cells, Cultured
  • Decision Support Techniques*
  • Humans
  • Metal Nanoparticles / chemistry
  • Metal Nanoparticles / classification
  • Metal Nanoparticles / toxicity*
  • Mutagenicity Tests
  • Nanotubes, Carbon / chemistry
  • Nanotubes, Carbon / classification
  • Nanotubes, Carbon / toxicity*
  • No-Observed-Adverse-Effect Level
  • Particle Size
  • Risk Assessment
  • Solubility
  • Surface Properties
  • Toxicity Tests / methods*
  • Toxicity Tests / standards
  • Workflow*

Substances

  • Nanotubes, Carbon